Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mark P. Jarrett"'
Autor:
Mitsuaki Nishikimi, Daniel Jafari, Neha Singh, Koichiro Shinozaki, Cristina P. Sison, Muhammad Shoaib, Jonathan Gong, Rehana Rasul, Timmy Li, Kei Hayashida, Daniel M. Rolston, Santiago J. Miyara, Jamie S. Hirsch, Amir Gandomi, Maureen T. White, Mark P. Jarrett, Martin L. Lesser, Lance B. Becker, Matthew A. Barish, Douglas P. Barnaby, Edith Burns, Jennifer Cookingham, Zachary M. Kozel, Ernesto P. Molmenti, Rachel Monane, Marc d. Paradis
Publikováno v:
Annals of the American Thoracic Society. 19:1346-1354
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d414a30890c0baa85b9918c7cb37bb6
https://doi.org/10.1513/annalsats.202106-705oc
https://doi.org/10.1513/annalsats.202106-705oc
Autor:
Molly Rae Kobritz, Samuel Paul Dechario, David Rindskopf, Gregg Husk, Mark P Jarrett, Vihas Patel, Gary Giangola, Anthony C Antonacci
Publikováno v:
Journal of the American College of Surgeons. 236:S36-S36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e26330d52c95083c4a03e776747b8af7
https://doi.org/10.1097/01.xcs.0000932568.19378.48
https://doi.org/10.1097/01.xcs.0000932568.19378.48
Autor:
Warren Licht, Steve Bello, Mark P. Jarrett, Kevin Coppa, Jamie S. Hirsch, Ira S. Nash, Rajdeep Brar, Kevin Bock, Zenobia Brown
ImportanceNeutralizing monoclonal antibody (MAB) therapies may benefit patients with mild to moderate COVID-19 at high risk for progressing to severe COVID-19 and/or hospitalization. Studies documenting approaches to deliver MAB infusions as well as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a2451efd0094d8fced45db699848e99
https://doi.org/10.1101/2021.04.09.21255219
https://doi.org/10.1101/2021.04.09.21255219
Autor:
Karen Nelson, Lori Stier, Susanne F. Schultz, Marcella De Geronimo, Jason J Wang, Julie S. Lyall, Mark P. Jarrett
Publikováno v:
Journal of Medical Internet Research, Vol 22, Iss 9, p e23565 (2020)
medRxiv
medRxiv
Background Northwell Health, an integrated health system in New York, has treated more than 15,000 inpatients with COVID-19 at the US epicenter of the SARS-CoV-2 pandemic. Objective We describe the demographic characteristics of patients who died of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d024bf2043b7482334345f0f8f3fffc7
http://www.jmir.org/2020/9/e23565/
http://www.jmir.org/2020/9/e23565/
Autor:
Mark P. Jarrett, Susanne E. Schultz, Julie S. Lyall, Jason J. Wang, Lori Stier, Marcella De Geronimo, Karen L. Nelson
Publikováno v:
Journal of Medical Internet Research
BackgroundNorthwell Health (Northwell), an integrated health system in New York, treated more than 15000 inpatients with coronavirus disease (COVID-19) at the US epicenter of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b90917f4e1d505a1ea3c886a4ef05fb
https://pubmed.ncbi.nlm.nih.gov/32930099
https://pubmed.ncbi.nlm.nih.gov/32930099
Publikováno v:
Journal of Emergency Management. 16:95-106
Hospitals are faced with the difficult decision as whether to evacuate their patients or shelter in place when a strong hurricane is predicted to affect the facility. This decision must balance for patients the risk of transport with the risk of stay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec5ca9376fada49d2bd40e2be144e797
https://doi.org/10.5055/jem.2018.0358
https://doi.org/10.5055/jem.2018.0358
Autor:
Warren Licht, Zenobia Brown, Ira S. Nash, Stephen Bello, Kevin Bock, Mark P. Jarrett, Rajdeep Brar, Jamie S. Hirsch, Kevin Coppa
Publikováno v:
JMIRx Med. 2:e33496
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08da107d29aad67c5a7ebfbfaf348a4e
https://doi.org/10.2196/33496
https://doi.org/10.2196/33496
Autor:
Mark P. Jarrett, Warren Licht, Stephen Bello, Zenobia Brown, Ira S. Nash, Kevin Bock, Rajdeep Brar, Jamie S. Hirsch, Kevin Coppa
Publikováno v:
Jmirx Med
Background Neutralizing monoclonal antibody (MAB) therapies may benefit patients with mild to moderate COVID-19 at high risk for progressing to severe COVID-19 or hospitalization. Studies documenting approaches to deliver MAB infusions and demonstrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157f1e5477b6f748a71fc4cc0e4e64a4
https://doi.org/10.2196/29638
https://doi.org/10.2196/29638
Autor:
Mark P. Jarrett
Publikováno v:
Journal of Healthcare Management. 62:88-92
How will I know when my hospital is safe?" To that question, many hospital CEOs would likely answer, "When I no longer have to call ahead to let staff know a family member is being admitted."Patient safety has been a strategic imperative in healthcar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::486be3aa55f236ca67d150ab12012a6b
https://doi.org/10.1097/jhm-d-17-00005
https://doi.org/10.1097/jhm-d-17-00005
Autor:
Mark P. Jarrett
Publikováno v:
Annals of Internal Medicine. 170:283
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4671bbc29156b909c04aab86d04392e5
https://doi.org/10.7326/l18-0635
https://doi.org/10.7326/l18-0635